MP59-09 NOVEL COMPOSITE ‘BPH3’trifecta FOR ROBOTIC ASSISTED SIMPLE PROSTATECTOMY (RASP) VS BPH6; A MULTICENTER OUTCOMES COMPARISON

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP59-09 NOVEL COMPOSITE ‘BPH3’trifecta FOR ROBOTIC ASSISTED SIMPLE PROSTATECTOMY (RASP) VS BPH6; A MULTICENTER OUTCOMES COMPARISON Alfredo Maria Bove, Aldo Brassetti, Riccardo Mastroianni, Gabriele Tuderti, Umberto Anceschi, Simone D'Annunzio, Mariaconsiglia Ferriero, Leonardo Misuraca, Iannuzzi Andrea, Prata Francesco, Alberto Ragusa, Michele Gallucci, Simone Giuseppe, Porpiglia Francesco, Daniele Amparore, Sabrina De Cillis, Alberto Quarà, Michele Ortenzi, Cristian Fiori, and Checcucci Enrico Alfredo Maria BoveAlfredo Maria Bove More articles by this author , Aldo BrassettiAldo Brassetti More articles by this author , Riccardo MastroianniRiccardo Mastroianni More articles by this author , Gabriele TudertiGabriele Tuderti More articles by this author , Umberto AnceschiUmberto Anceschi More articles by this author , Simone D'AnnunzioSimone D'Annunzio More articles by this author , Mariaconsiglia FerrieroMariaconsiglia Ferriero More articles by this author , Leonardo MisuracaLeonardo Misuraca More articles by this author , Iannuzzi AndreaIannuzzi Andrea More articles by this author , Prata FrancescoPrata Francesco More articles by this author , Alberto RagusaAlberto Ragusa More articles by this author , Michele GallucciMichele Gallucci More articles by this author , Simone GiuseppeSimone Giuseppe More articles by this author , Porpiglia FrancescoPorpiglia Francesco More articles by this author , Daniele AmparoreDaniele Amparore More articles by this author , Sabrina De CillisSabrina De Cillis More articles by this author , Alberto QuaràAlberto Quarà More articles by this author , Michele OrtenziMichele Ortenzi More articles by this author , Cristian FioriCristian Fiori More articles by this author , and Checcucci EnricoCheccucci Enrico More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003312.09AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: BPH6 is a comprehensive metric to assess outcomes after treatment for BPO. Since the BPH6 includes: reduction of <6 points in International Index of Erectile Function (IIEF) and persistence of antegrade ejaculation at Male Sexual Health Questionnaire (MSHQ), only a small percentage of disobstructive procedures can lead to its achievement. We tested our novel BPH3 trifecta, in assessing the disobstructive proficiency of RASP according to different techniques. METHODS: Baseline prostate volume (PV), flowmetry parameters and Validated questionnaires: IIEF, Incontinence severity index score (ISI), International prostatic symptoms score (IPSS), MSHQ, Quality of recovery (QOR), were recorded preoperatively and 12 months postoperatively. RASP were performed according to the urethra-sparing (Madigan) technique and a non urethra-sparing trans-vescical (Freyer) approach. The 2 cohorts were tested for our novel composite BPH-3 achievement rate as well as for BPH-6 achievement rate. BPH3 was defined as: ΔIPSS≥30%, ISI score≤4, and No complications Clavien>1. RESULTS: 158 patients underwent RASP (93 Madigan and 65 Freyer). Patients scheduled for Madigan procedure were younger, with lower PV, baseline IPSS score, overactive symptoms (ISI score), but higher MSHQ and IIEF score, when compared to the Freyer population (all p<0.02) (Table 1). At 12 months follow-up, Madigan patients reported a shorter bladder irrigation time and time to catheter removal (both p<0.001). A superiority in postoperative IEEF and MSHQ score were reported by the Madigan patients as expected (all p<0.001). Postoperative complication incidence was higher in the Madigan cohort, mainly due to UTI (p<0.001). Although there were no differences in postoperative IPSS and Q-max between groups, the Madigan cohort presented with higher post void residue (p<0.001) (Table 2). BPH6 achievement was higher in the Madigan cohort (48% vs 28%) (p<0.001), while no difference was found in BPH3 achievement rate. CONCLUSIONS: Novel BPH3 composite trifecta appears to be more suitable than BPH6 in assessing the proficiency in disobstructive symptoms relief after RASP. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e810 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Alfredo Maria Bove More articles by this author Aldo Brassetti More articles by this author Riccardo Mastroianni More articles by this author Gabriele Tuderti More articles by this author Umberto Anceschi More articles by this author Simone D'Annunzio More articles by this author Mariaconsiglia Ferriero More articles by this author Leonardo Misuraca More articles by this author Iannuzzi Andrea More articles by this author Prata Francesco More articles by this author Alberto Ragusa More articles by this author Michele Gallucci More articles by this author Simone Giuseppe More articles by this author Porpiglia Francesco More articles by this author Daniele Amparore More articles by this author Sabrina De Cillis More articles by this author Alberto Quarà More articles by this author Michele Ortenzi More articles by this author Cristian Fiori More articles by this author Checcucci Enrico More articles by this author Expand All Advertisement PDF downloadLoading ...